Advertisement
U.S. markets open in 1 minute
  • S&P Futures

    5,310.50
    +2.25 (+0.04%)
     
  • Dow Futures

    40,187.00
    +43.00 (+0.11%)
     
  • Nasdaq Futures

    18,505.75
    +2.00 (+0.01%)
     
  • Russell 2000 Futures

    2,140.70
    +2.30 (+0.11%)
     
  • Crude Oil

    82.48
    +1.13 (+1.39%)
     
  • Gold

    2,232.50
    +19.80 (+0.89%)
     
  • Silver

    24.77
    +0.02 (+0.09%)
     
  • EUR/USD

    1.0810
    -0.0020 (-0.18%)
     
  • 10-Yr Bond

    4.2120
    +0.0160 (+0.38%)
     
  • Vix

    12.96
    +0.18 (+1.41%)
     
  • GBP/USD

    1.2633
    -0.0005 (-0.04%)
     
  • USD/JPY

    151.3200
    +0.0740 (+0.05%)
     
  • Bitcoin USD

    70,854.58
    -407.22 (-0.57%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,953.19
    +21.21 (+0.27%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

UPDATE: Morgan Stanley Reiterates On Re/Max As Strong Agent Growth Continues

In a report published Tuesday, Morgan Stanley analyst Vikram Malhotra reiterated an Overweight rating on Re/Max Holdings (NYSE: RMAX), but removed the $35.00 price target.

In the report, Morgan Stanley noted, “Strong agent growth continued in May, up 5.5% y/y, which is flat with April's growth rate and still close to a seven-year high. May data from the National Association of Realtors (NAR) shows agents in the US grew by 1.4% m/m to ~1.05 mn, much better than a historical 0.5% m/m increase in May. NAR agent count correlates closely with Re/Max's on a y/y basis, but there could be differences by quarter.

"Agent growth (the company's main top line driver) is generally a key metric for the company's earnings. Agent growth has been strong in 2014, averaging 5.5%. We believe this bodes well for RMAX and estimate the company's US agent base to grow by 5.8% in 2Q on back of strong industry growth.”

Re/Max closed on Monday at $28.54.

Related Links

© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement